Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trials of New Chemopreventive Agents
Messing, E.
University of Wisconsin Madison, Madison, WI, United States
Search 254 grants from E. Messing
Search grants from University of Wisconsin Madison
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Medicinal Chemistry of Hallucinogenic Drugs
Efficacy, safety &tolerability of BRL 996536C in NIDDM
Dose Escalation of Dmp 777 Lung Specific Bioefficacy in Adult Cf Pts
Macrophage Growth: Role of Colony Stimulating Factor
Calcium Transport in Streptocuccus Sanguis
Recently added grants:
A 'Culture' Shift: Integrated Bacterial Screening and Antibacterial Susceptibility Test on Microfluidic Digital Array for Bloodstream Infections
Mechanisms of Innate Immune Evasion by Mycobacterium Tuberculosis
A host-dependent mechanism controlling influenza virus infection by suppressing viral RNA synthesis
Function and mechanism of the mammalian RNA interference response to virus infection
Structure, Function and Mechanistic Analysis of LAG3
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025434-001
Application #
2302098
Study Section
Project Start
1993-06-15
Project End
Budget Start
1993-06-15
Budget End
1999-06-15
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Related projects
NIH 1999
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Carbone, Paul P. / University of Wisconsin Madison
NIH 1997
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Carbone, Paul P. / University of Wisconsin Madison
NIH 1996
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Carbone, Paul P. / University of Wisconsin Madison
NIH 1993
N01 CN
Phase II Clinical Trials of New Chemopreventive Agents
Messing, E. / University of Wisconsin Madison
Publications
Messing, Edward; Kim, Kyung Mann; Sharkey, Francis et al.
(2006)
Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
J Urol 176:500-4
Comments
Be the first to comment on this grant
